跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lelucazine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lelucazine
Approved
STANDARD
Lelucazine
Cooper Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6898a33bd762986f
Company
Cooper Pharma Limited
Type
Standard
Approval Details
Approval Id
6898a33bd762986f
Drug Approval Philippines Name
Lelucazine
Product Name
Lelucazine
Registration Number
DRP-11851-13
Brand Name
Lelucazine
Generic Name
Montelukast (as sodium) + Levocetirizine Hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg / 5 mg
Manufacturer
Cooper Pharma Limited
Importer
Ambica International Corporation
Distributor
Maed Pharma Corporation
Issuance Date
27 September 2024
Expiry Date
10 May 2027
Pharmacologic Category
Leukotriene Receptor Antagonist / Antihistamine
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6898a33bd762986f
Type
Standard
Back to Philippines FDA Approvals